These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 22639888)

  • 21. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment.
    Swerdlow AJ; Barber JA; Hudson GV; Cunningham D; Gupta RK; Hancock BW; Horwich A; Lister TA; Linch DC
    J Clin Oncol; 2000 Feb; 18(3):498-509. PubMed ID: 10653865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients.
    de Vries S; Schaapveld M; Janus CPM; Daniëls LA; Petersen EJ; van der Maazen RWM; Zijlstra JM; Beijert M; Nijziel MR; Verschueren KMS; Kremer LCM; van Eggermond AM; Lugtenburg PJ; Krol ADG; Roesink JM; Plattel WJ; van Spronsen DJ; van Imhoff GW; de Boer JP; Aleman BMP; van Leeuwen FE
    J Natl Cancer Inst; 2021 Jun; 113(6):760-769. PubMed ID: 33351090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma.
    Neppelenbroek SIM; Geurts YM; Aleman BMP; Lugtenburg PJ; Rademakers SE; de Weijer RJ; Schippers MGA; Ta BDP; Plattel WJ; Zijlstra JM; van der Maazen RWM; Nijziel MR; Ong F; Schimmel EC; Posthuma EFM; Kersten MJ; Böhmer LH; Muller K; Koene HR; Te Boome LCJ; Bilgin YM; de Jongh E; Janus CPM; van Leeuwen FE; Schaapveld M
    J Clin Oncol; 2024 Jun; 42(16):1903-1913. PubMed ID: 38359378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
    Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
    Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
    Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
    N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study.
    Swerdlow AJ; Higgins CD; Smith P; Cunningham D; Hancock BW; Horwich A; Hoskin PJ; Lister TA; Radford JA; Rohatiner AZ; Linch DC
    J Clin Oncol; 2011 Nov; 29(31):4096-104. PubMed ID: 21969511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in France.
    Jabagi MJ; Vey N; Goncalves A; Le Tri T; Zureik M; Dray-Spira R
    JAMA Netw Open; 2019 Jan; 2(1):e187147. PubMed ID: 30657534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term complications in Hodgkin's lymphoma survivors.
    Kilickap S; Barista I; Ulger S; Celik I; Selek U; Güllü I; Yildiz F; Kars A; Ozisik Y; Tekuzman G
    Tumori; 2012; 98(5):601-6. PubMed ID: 23235755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time--a population-based comparative study.
    Glimelius I; Ekberg S; Linderoth J; Jerkeman M; Chang ET; Neovius M; Smedby KE
    J Cancer Surviv; 2015 Dec; 9(4):599-609. PubMed ID: 25689964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma.
    Lee L; Pintilie M; Hodgson DC; Goss PE; Crump M
    Ann Oncol; 2008 Jan; 19(1):62-7. PubMed ID: 17878177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood.
    van Leeuwen FE; Klokman WJ; Veer MB; Hagenbeek A; Krol AD; Vetter UA; Schaapveld M; van Heerde P; Burgers JM; Somers R; Aleman BM
    J Clin Oncol; 2000 Feb; 18(3):487-97. PubMed ID: 10653864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of second malignancies in patients with early-stage classical Hodgkin's lymphoma treated in a modern era.
    LeMieux MH; Solanki AA; Mahmood U; Chmura SJ; Koshy M
    Cancer Med; 2015 Apr; 4(4):513-8. PubMed ID: 25620577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer in young women after treatment for Hodgkin's disease during childhood or adolescence--an observational study with up to 33-year follow-up.
    Schellong G; Riepenhausen M; Ehlert K; Brämswig J; Dörffel W; ; Schmutzler RK; Rhiem K; Bick U;
    Dtsch Arztebl Int; 2014 Jan; 111(1-2):3-9. PubMed ID: 24565270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation.
    Salloum E; Doria R; Schubert W; Zelterman D; Holford T; Roberts KB; Farber LR; Kiehl RK; Cardinale J; Cooper DL
    J Clin Oncol; 1996 Sep; 14(9):2435-43. PubMed ID: 8823321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Radiation and Procarbazine Dose With Risk of Colorectal Cancer Among Survivors of Hodgkin Lymphoma.
    Geurts YM; Shakir R; Ntentas G; Roberti S; Aznar MC; John KM; Ramroth J; Janus CPM; Krol ADG; Roesink JM; van der Maazen RWM; Zijlstra JM; Darby SC; Aleman BMP; van Leeuwen FE; Cutter DJ; Schaapveld M
    JAMA Oncol; 2023 Apr; 9(4):481-489. PubMed ID: 36729438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcomes in Hodgkin lymphoma survivors. Temporary trends and comparison with general population.
    Núñez-García B; Clemente MB; Sánchez JC; Royuela A; Ibargüen BCS; Méndez M; López-Ibor JV; Martínez M; Traseira C; Garitaonaindia Y; Aguado R; Calvo V; Torrente M; Parejo C; Provencio Z; Provencio M
    Hematol Oncol; 2023 Aug; 41(3):407-414. PubMed ID: 36934306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fertility outcome of breast cancer and Hodgkin's lymphoma female survivors: a growing clinical challenge for gynecologists and oncologists.
    Gadducci A; Tana R; Sergiampietri C; Guiggi I
    Gynecol Endocrinol; 2013 Aug; 29(8):729-34. PubMed ID: 23751054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrointestinal cancer after treatment of Hodgkin's disease.
    Birdwell SH; Hancock SL; Varghese A; Cox RS; Hoppe RT
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):67-73. PubMed ID: 9054878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk for second malignancies in non-Hodgkin's lymphoma survivors: a meta-analysis.
    Pirani M; Marcheselli R; Marcheselli L; Bari A; Federico M; Sacchi S
    Ann Oncol; 2011 Aug; 22(8):1845-58. PubMed ID: 21310758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of Valvular Disorders in Survivors of Hodgkin's Lymphoma Treated by Mediastinal Radiotherapy ± Chemotherapy.
    Bijl JM; Roos MM; van Leeuwen-Segarceanu EM; Vos JM; Bos WW; Biesma DH; Post MC
    Am J Cardiol; 2016 Feb; 117(4):691-696. PubMed ID: 26772441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.